Congenital Lobar Emphysema
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Congenital Lobar Emphysema

What is the definition of Congenital Lobar Emphysema?
Congenital lobar emphysema is a rare respiratory disorder in which air can enter the lungs but cannot escape, causing overinflation (hyperinflation) of the lobes of the lung. It is most often detected in newborns or young infants, but some cases do not become apparent until adulthood. Signs and symptoms may include difficulty breathing and respiratory distress in infancy, an enlarged chest, compressed lung tissue, cyanosis, and underdevelopment of the cartilage that supports the bronchial tube (bronchial hypoplasia). This disorder may be severe enough to cause associated heart problems (15% of cases) or so mild as to never become apparent. Some cases may be caused by autosomal dominant inheritance while others occur for no apparent reason (sporadic).
What are the alternative names for Congenital Lobar Emphysema?
  • Congenital lobar emphysema
  • CLE
  • Emphysema, congenital lobar
Who are the top Congenital Lobar Emphysema Local Doctors?
Elite in Congenital Lobar Emphysema
General Surgery
Elite in Congenital Lobar Emphysema
General Surgery
Referral may be required

Rubenstein Child Health Building

200 North Wolfe Street, Rubenstein BLDG Lower Level, Rubenstein BLDG Lower Level, 
Baltimore, MD 
Languages Spoken:
English

Shaun M. Kunisaki, MD, MSc, is Professor of Surgery at the Johns Hopkins School of Medicine, a Robert & Jane Meyerhoff Professor at Johns Hopkins University, and Associate Chief of Strategy and Integration in the Division of General Pediatric Surgery at the Johns Hopkins Children's Center. Dr. Kunisaki's clinical practice spans the full breadth of pediatric general, thoracic, and fetal surgery, but he is a nationally and internationally recognized authority in the prenatal and postnatal management of congenital thoracic anomalies, including lung malformations, esophageal atresia, and congenital diaphragmatic hernia. He is the Director of the Fetal Program in General Pediatric Surgery and chairs the Prenatal Pediatrics Steering Committee, a collaboration between the Johns Hopkins Children's Center and the Department of Gynecology & Obstetrics at the Johns Hopkins Hospital. As Director of the Pediatric Esophageal Center, he specializes in the management of complex esophageal disorders such as long-gap esophageal atresia. He serves on the Editorial Board of several journals, including Pediatrics and Surgery, and holds senior leadership positions in the American Pediatric Surgical Association (APSA), Section on Surgery of the American Academy of Pediatrics (AAP), and the Society of University Surgeons (SUS). Dr. Kunisaki has published over 100 peer-reviewed manuscripts and book chapters. His laboratory is funded by the National Institutes of Health and is largely focused on using stem cells derived from a patient's own tissues to better understand and treat several important pediatric surgical diseases. His team has developed techniques to reprogram fetal and neonatal tissues into pluripotent stem cells and organoids, and are working with scientists and engineers to improve long-term outcomes for children with severe birth defects, including spina bifida and congenital diaphragmatic hernia. More recently, he founded the Eastern Pediatric Surgery Network (EPSN), a clinical research collaborative composed of pediatric surgeons from over 20 children's hospitals in the country. A native of southern California, Dr. Kunisaki graduated with honors from Harvard College, the London School of Economics and Political Science, and Harvard Medical School. He completed general surgery residency at the Massachusetts General Hospital/Harvard Medical School followed by a pediatric surgery fellowship at the University of Michigan. He also did additional research fellowships at the Massachusetts General Hospital and at Boston Children's Hospital. Philanthropy plays a crucial role in the work Dr. Kunisaki does by providing seed funding for research, funding for the best educational resources to train the future generation of pediatric surgeons, and additional support services for families receiving treatment that are not covered by insurance. Support Dr. Kunisaki. Dr. Kunisaki is rated as an Elite provider by MediFind in the treatment of Congenital Lobar Emphysema. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Congenital Lobar Emphysema, Diaphragmatic Hernia, Congenital Diaphragmatic Hernia, Appendectomy, and Endoscopy. Dr. Kunisaki is board certified in American Board Of Surgery.

Elite in Congenital Lobar Emphysema
Elite in Congenital Lobar Emphysema
Referral may be required
Beersheba, D, IL 

Dvir Gatt practices practicing medicine in Beersheba, Israel. Mr. Gatt is rated as an Elite expert by MediFind in the treatment of Congenital Lobar Emphysema. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Congenital Lobar Emphysema, Dextrocardia with Situs Inversus, Dextrocardia, Situs Inversus, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Congenital Lobar Emphysema
General Surgery
Advanced in Congenital Lobar Emphysema
General Surgery
Referral may be required

Prisma Health Pediatric Surgery – Greenville

48 Cross Park Court, 
Greenville, SC 
Languages Spoken:
English
Accepting New Patients

Robert Gates is a General Surgeon practicing medicine in Greenville, South Carolina. Dr. Gates is rated as an Advanced provider by MediFind in the treatment of Congenital Lobar Emphysema. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Congenital Lobar Emphysema, Pectus Excavatum, Biliary Dyskinesia, Gastrostomy, and Splenectomy. Dr. Gates is currently accepting new patients.

What are the latest Congenital Lobar Emphysema Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center